T1	Participants 103 152	patients with advanced non-small-cell lung cancer
T2	Participants 240 284	advanced non-small-cell lung cancer (NSCLC).
T3	Participants 461 538	Between January 1995 and April 1996, 414 patients with stage IIIB or IV NSCLC
